These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An evaluation of leukaemia inhibitory factor as a potential therapeutic agent in the treatment of muscle disease. White JD, Davies M, McGeachie J, Grounds MD. Neuromuscul Disord; 2002 Dec; 12(10):909-16. PubMed ID: 12467745 [Abstract] [Full Text] [Related]
3. Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse. Kurek J, Bower J, Romanella M, Austin L. Neurosci Lett; 1996 Jul 19; 212(3):167-70. PubMed ID: 8843099 [Abstract] [Full Text] [Related]
16. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice. Krämer R, Lochmüller H, Abicht A, Rüdel R, Brinkmeier H. Neuromuscul Disord; 1998 Dec 19; 8(8):542-50. PubMed ID: 10093060 [Abstract] [Full Text] [Related]
17. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Wineinger MA, Abresch RT, Walsh SA, Carter GT. Am J Phys Med Rehabil; 1998 Dec 19; 77(1):20-7. PubMed ID: 9482375 [Abstract] [Full Text] [Related]
18. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Gregorevic P, Plant DR, Leeding KS, Bach LA, Lynch GS. Am J Pathol; 2002 Dec 19; 161(6):2263-72. PubMed ID: 12466140 [Abstract] [Full Text] [Related]